Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 5, 2015

Study Completion Date

June 5, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

Acipimox

Subjects will take acipimox 250mg (randomized and double-blinded) by mouth four times a day for six days prior to the visit and one dose the morning of study visit.

DRUG

Placebo

Subjects will take a placebo pill 250mg (randomized and double-blinded) by mouth four times a day for six days prior to the visit and one dose the morning of study visit.

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

collaborator

Pfizer

INDUSTRY

lead

University of Colorado, Denver

OTHER

NCT01580813 - Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes | Biotech Hunter | Biotech Hunter